Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Most Accessed Articles
C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
, 2021; 19(7): 1038-1068.Sivakami Mylvaganam, Rebecca Earnshaw, Gregory Heymann, Suneil K. Kalia and Lorraine V. Kalia*
DOI: 10.2174/1570159X18666201116145507
Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease
, 2021; 19(7): 908-924.Sadayuki Hashioka*, Zhou Wu and Andis Klegeris*
DOI: 10.2174/1570159X18666201111104509
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
, 2021; 19(7): 957-989.Sukriti Vishwas, Monica Gulati, Bhupinder Kapoor, Saurabh Gupta*, Sachin Kumar Singh*, Ankit Awasthi, Arzoo Khan, Aditya Goyal, Anil Bansal, Suman Baishnab, Thakur Gurjeet Singh, Sandeep Arora, Omji Porwal, Ankit Kumar and Vijay Kumar
DOI: 10.2174/1570159X18666201109090824
A Systematic Review of the MDMA Model to Address Social Impairment in Autism
, 2021; 19(7): 1101-1154.Devahuti Chaliha, John C. Mamo, Matthew Albrecht, Virginie Lam, Ryu Takechi and Mauro Vaccarezza*
DOI: 10.2174/1570159X19666210101130258
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke
, 2020; 18(12): 1250-1265.Yi Yang* and Michel T. Torbey
DOI: 10.2174/1570159X18666200720173316
The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System
, 2021; 19(7): 1090-1100.Cheong-Meng Chong*, Zhangfeng Zhong, Chi Teng Vong, Shengpeng Wang, Jin-Jian Lu, Hai-Jing Zhong, Huanxing Su and Yitao Wang*
DOI: 10.2174/1570159X18666201029150937
Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
, 2021; 19(7): 1007-1018.Fabiana Labanca, Hammad Ullah, Haroon Khan*, Luigi Milella, Jianbo Xiao, Zora Dajic-Stevanovic and Philippe Jeandet
DOI: 10.2174/1570159X18666200522201123
Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach
, 2021; 19(7): 990-1006.Koumudhi Rajanala, Nitesh Kumar and Mallikarjuna Rao Chamallamudi*
DOI: 10.2174/1570159X19666201215142520
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
, 2021; 19(7): 1069-1089.Adejoke Y. Onaolapo* and Olakunle J. Onaolapo
DOI: 10.2174/1570159X18666201015161919
SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan
, 2021; 19(7): 1019-1037.Priya Mishra, Amit Kumar Mittal, Harikesh Kalonia, Swati Madan, Shampa Ghosh, Jitendra Kumar Sinha* and Satyendra Kumar Rajput*
DOI: 10.2174/1570159X18666200729111744
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis
, 2021; 19(7): 925-938.Santiago J. Ballaz* and Michel Bourin
DOI: 10.2174/1570159X18666201113145143
Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway
, 2021; 19(7): 939-956.María Jesús Ramírez-Expósito, Jose Manuel Martínez-Martos, Vanesa Cantón-Habas and María del Pilar Carrera-González*
DOI: 10.2174/1570159X18666201111103024
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
, 2021; 19(5): 610-628.Carla Petrella*, Stefano Farioli-Vecchioli, Giusy Ylenia Cisale, Georgios Strimpakos, John Joseph Borg, Mauro Ceccanti, Marco Fiore*, Giovanni Monteleone and Robert Nisticò
DOI: 10.2174/1570159X18666200730111528
Crosstalk between Inflammation and the BBB in Stroke
, 2020; 18(12): 1227-1236.Yuyou Huang, Shengpan Chen, Yumin Luo* and Ziping Han*
DOI: 10.2174/1570159X18666200620230321
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy
, 2021; 19(2): 220-232.Itay Lotan*, Richard McGowan and Michael Levy
DOI: 10.2174/1570159X18666200429010825
Emerging Evidence for Neuropsycho-Consequences of COVID-19
, 2021; 19(1): 92-96.Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Fang Fang, Xuefei Lv, Dandan Zhang, Yu Sun, Na Li, Shaoping Hu, Zhicheng Lin* and Nian Xiong*
DOI: 10.2174/1570159X18666200507085335
Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation
, 2020; 18(11): 1064-1075.Alexander N. Orekhov*, Anastasia V. Poznyak, Igor A. Sobenin, Nikita N. Nikifirov and Ekaterina A. Ivanova
DOI: 10.2174/1570159X17666191118125018
Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis
, 2021; 19(4): 538-552.Brayan Jonas Mano-Sousa, Alessandra Moraes Pedrosa, Bruna Cristina Alves, José Carlos Fernandes Galduróz, Vinícius Silva Belo, Valéria Ernestânia Chaves and Joaquim Maurício Duarte-Almeida*
DOI: 10.2174/1570159X18666200529151741
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
, 2021; 19(5): 641-664.Mary Jasmin Ang, Sueun Lee, Jong-Choon Kim, Sung-Ho Kim and Changjong Moon*
DOI: 10.2174/1570159X18666200814175114
Editor-in-Chief
Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
(Italy)
Department of Pharmaceutical Sciences
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net